Sending Tissue Samples to Space for MS, Parkinson’s Research
NSCF will send human brain organoids derived from patients with two different types of degenerative brain diseases—Parkinson’s and PPMS—to the orbiting laboratory.
NSCF will send human brain organoids derived from patients with two different types of degenerative brain diseases—Parkinson’s and PPMS—to the orbiting laboratory.
In a new study, researchers found a derivative of good fats may relieve symptoms in patients with chronic inflammatory diseases, such as Multiple Sclerosis.
In people with secondary progressive MS, hematopoietic stem cell transplants may delay disability longer than some other MS medications.
People older than 45 whose Type 2 diabetes was treated with anti-hyperglycemic diabetes medications had a higher risk of multiple sclerosis.
Read MoreResearchers have developed a new methodology to calculate the delay of signal propagations in the brains of patients with multiple sclerosis.
Read MoreResearchers have developed a model that can predict how stay-at-home orders affect the mental health of people with neurological disorders.
Read MoreKessler Foundation researchers weigh in regarding exoskeletons, a current controversy in the management of people with multiple sclerosis.
Read MoreXRHealth publishes a new study suggesting that virtual reality technology is viable in treating upper limb dysfunction in MS patients.
Read MoreThalamic atrophy needs to be considered in clinical studies of the functional abilities of individuals with multiple sclerosis, per research.
Read MoreNational Multiple Sclerosis Society awards grant to Kessler Foundation’s John DeLuca, PhD, to continue multiple sclerosis curriculum.
Read MoreAccelerated Cure Project and others are collaborating to study immune response to COVID-19 vaccinations of people living with MS.
Read MoreA new analysis shows that the amount a country spends on health care may help explain the link between MS and latitude.
Read MoreThe Multiple Sclerosis Association of America launches the Ultimate MS Treatment Guide to help people with MS learn about therapies.
Read MoreHelius Medical Technologies Inc, a neurotech company, reports financial results for the quarter that ended June 30, 2022.
Read MoreA MedUni Vienna study suggests that the retina can be used as a prognostic marker to predicts the severity of future MS relapses.
Read MoreFor people with multiple sclerosis, there are specific factors that may affect a person’s physical and mental quality of life.
Read MoreMultiple sclerosis patients receiving anti-CD20 therapy saw strong T-cell activation after receiving two doses of the COVID-19 vaccine.
Read MoreMymee has acquired Berlin-based Breakthrough Health, the creator of the mobile app Emilyn for people with multiple sclerosis (MS).
Read More